MONITORING OF TNF-ALPHA BLOCKERS INFLIXIMAB AND ADALIMUMAB BY MEASURING TROUGH LEVEL CONCENTRATIONS AND ANTI-DRUG ANTIBODIES

被引:0
|
作者
Westerlund, Johanna [1 ]
Jokiranta, T. Sakari [1 ,2 ]
机构
[1] United Medix Labs Ltd, Espoo, Finland
[2] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, FIN-00014 Helsinki, Finland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:325 / 325
页数:1
相关论文
共 50 条
  • [1] Cost-effectiveness of routine measuring of serum drug concentrations and anti-drug antibodies in treatment of rheumatoid arthritis patients with TNF-alpha blockers
    Laine, Juha
    Jokiranta, T. Sakari
    Eklund, Kari K.
    Vakevainen, Merja
    Puolakka, Kari
    [J]. BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 67 - 73
  • [2] Anti-drug Antibodies Inhibit Neutralization of TNF-alpha in Infliximab Treated Patients with Inflammatory Bowel Disease (IBD)
    Eser, A.
    Vogelsang, H.
    Reinisch, S.
    Novacek, G.
    Dejaco, C.
    Kazemi-Shirazi, L.
    Primas, C.
    Lichtenberger, C.
    Brehovsky, S.
    Singh, S.
    Jain, A.
    Reinisch, W.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S304 - S305
  • [3] USEFULNESS OF MONITORING THE CLINICAL COURSE OF INFLAMMATORY BOWEL DISEASES THROUGH THE DETERMINATION OF INFLIXIMAB OR ADALIMUMAB TROUGH LEVELS AND BY THE EVALUATION OF ANTI-DRUG ANTIBODIES
    Miranda, A.
    Sgambato, D.
    Ferrante, E.
    Picascia, D.
    Avallone, L.
    D'Amico, M.
    Sullo, M. G.
    Capuano, A.
    Romano, M.
    [J]. DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E133 - E133
  • [4] Predictors of sub-therapeutic infliximab or adalimumab trough levels and anti-drug antibodies and their influence on therapeutic decisions
    Goldberg, R.
    Beswick, L.
    Van Langenberg, D.
    Sally, B.
    Rosella, O.
    Gibson, P.
    Moore, G.
    [J]. JOURNAL OF CROHNS & COLITIS, 2014, 8 : S223 - S223
  • [5] Anti-TNF and Anti-Drug Antibodies Levels Predict the Outcomes of Interventions After Loss of Response to Adalimumab and Infliximab
    Yanai, Henit
    Lichtenstein, Lev
    Assa, Amit
    Mazor, Yoav
    Weiss, Batia
    Levine, Arie
    Ron, Yulia
    Kopylov, Uri
    Bujanover, Yoram
    Rosenbach, Yoram
    Ungar, Bella
    Eliakim, Abraham R.
    Chowers, Yehuda
    Shamir, Raanan
    Fraser, Gerald
    Dotan, Iris
    Ben-Horin, Shomron
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S381 - S381
  • [6] REAL-LIFE INFLIXIMAB AND ADALIMUMAB TROUGH LEVEL AND ANTI-DRUG ANTIBODY MEASUREMENTS IN RHEUMATOLOGY: THE FINNISH EXPERIENCE
    Ho, D.
    Valtanen, S.
    Havana, M.
    Kroger, L.
    Eklund, K.
    Jokiranta, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 827 - 827
  • [7] Positivity thresholds of total infliximab and adalimumab anti-drug antibody assay: The prevalence of clearing and transient anti-drug antibodies in a national therapeutic drug monitoring service
    Nice, R.
    Chanchlani, N.
    Green, H.
    Bewshea, C.
    Kennedy, N.
    Ahmad, T.
    Goodhand, J.
    McDonald, T.
    Perry, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S018 - S019
  • [8] Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays
    Barclay, Murray L.
    Karim, Shwan
    Helms, Esther T. Johanna
    Keating, Paula E.
    Hock, Barry
    Stamp, Lisa K.
    Schultz, Michael
    [J]. INTERNAL MEDICINE JOURNAL, 2019, 49 (04) : 513 - 518
  • [9] MEASURING THE DIFFERENCE: COMPARISON OF MEASUREMENT OF FREE INFLIXIMAB ANTI-DRUG ANTIBODIES
    Hamilton, R.
    Shields, S.
    Mcgucken, A.
    Macdonald, J.
    Perry, M.
    Dunlop, A.
    Gribben, E.
    Galloway, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1449 - 1449
  • [10] DETECTING ADALIMUMAB SERUM LEVEL AND ANTI-DRUG ANTIBODIES - FUTURE TOOL IN MONITORING SPONDYLOARTHRITIS PATIENTS?
    Deaconu, C.
    Opris, D.
    Mazilu, D.
    Borangiu, A.
    Groseanu, L.
    Negru, M.
    Constantinescu, C.
    Saulescu, I.
    Bojinca, V.
    Vlad, V.
    Balanescu, A.
    Predeteanu, D.
    Ionescu, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : A75 - A75